15 results
8-K
EX-10.2
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
information regarding the Company or its Subsidiaries or their financial results or prospects.
(kk)Cybersecurity. (i)(x) There has been no security
8-K
EX-10.2
APVO
Aptevo Therapeutics Inc
4 Aug 23
Entry into a Material Definitive Agreement
6:51pm
for solicitation of purchasers in connection with the sale of any Securities.
(nn)Cybersecurity. (i) To the Company’s knowledge, in the three (3) years
DEFC14A
pzqeeh
11 May 21
Proxy in contested solicitation
8:55am
PREC14A
bxrjn7hbtwfyb6g9
28 Apr 21
Preliminary proxy with contested solicitation
4:20pm
8-K
EX-1.1
5ujwkpvduq9uh20 kw26
14 Dec 20
Entry into a Material Definitive Agreement
9:07am
- Prev
- 1
- Next